Seeing Is Believing
Currently out of the existing stock ratings of Tiago Fauth, 99 are a BUY (71.22%), 35 are a HOLD (25.18%), 5 are a SELL (3.6%).
Analyst Tiago Fauth works at CREDIT SUISSE with a stock forecast success ratio of 44.38% fulfilled within 112.86 days on average.
Tiago Fauth’s has documented 279 price targets and ratings displayed on 29 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on UTHR, United Therapeutics at 07-Mar-2024.
Analyst best performing recommendations are on HGEN (HUMANIGEN).
The best stock recommendation documented was for HGEN (HUMANIGEN) at 7/13/2022. The price target of $0.5 was fulfilled within 2 days with a profit of $0.11 (18.03%) receiving and performance score of 90.16.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
12
2 months 2 days ago
0/2 (0%)
$6.55 (120.18%)
Buy
8
$3.99 (99.50%)
6
3 months 19 days ago
0/2 (0%)
$2.16 (36.99%)
Buy
22
$17.99 (448.63%)
32
5 months 21 days ago
0/3 (0%)
$17.3 (368.09%)
Buy
24
$19.99 (498.50%)
30
8 months 20 days ago
0/2 (0%)
$17.96 (297.35%)
Buy
28
$23.99 (598.25%)
34
11 months 19 days ago
1/6 (16.67%)
$22.01 (367.45%)
24
Which stock is Tiago Fauth is most bullish on?
Which stock is Tiago Fauth is most reserved on?
What Year was the first public recommendation made by Tiago Fauth?